Description
A natural lignan that has in vitro and in vivo antiviral activities, blocking the replication of hepatitis B virus; has anti-inflammatory and anti-allodynic actions in vivo; inhibits topoisomerase 1B in Leishmania and elicits a Th1 immune response in mice, reducing liver and splenic parasite burden
Formal name: rel-6-[(2R,3R)-4-(3,4-dimethoxyphenyl)-2,3-bis(methoxymethyl)butyl]-4-methoxy-1,3-benzodioxole
Synonyms:
Molecular weight: 432.5
CAS: 50656-77-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Infectious Disease|Parasitic Diseases|Leishmaniasis||Research Area|Infectious Disease|Viral Diseases|Hepatitis